Feasibility of Total Mastectomy in Ambulatory Care
AMASTEC
1 other identifier
interventional
1
1 country
1
Brief Summary
Breast cancer is the first female cancer in France. Total mastectomy occurred in 30% of breast cancer patient population. The purpose of this study is to evaluate the feasibility of outpatient surgery for the total mastectomy. In France, Ambulatory care is developed as part of the new national health plan. Breast conserving surgery for tumorectomy or partial mastectomy is already done in outpatient vacation. Total mastectomy is an extension of this surgery, and, as such, underpins the investigator's hypothesis that total mastectomy is feasible in outpatient care .
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable breast-cancer
Started Jan 2021
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 12, 2020
CompletedFirst Posted
Study publicly available on registry
February 17, 2020
CompletedStudy Start
First participant enrolled
January 1, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 12, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
September 12, 2023
CompletedSeptember 13, 2023
September 1, 2023
2.7 years
February 12, 2020
September 12, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
number of ambulatory care after total mastectomy allowed with PADSS score
Post Anaesthetic Discharge Scoring System (PADSS), which considers six criteria: vital signs, ambulation, nausea/vomiting, pain, bleeding and voiding. Each criterion is given a score ranging from 0 to 2. Only patients who achieve a score of 9 or more are considered ready for discharge.
day 0= day of surgery
Study Arms (1)
breast cancer mastectomy
EXPERIMENTALInterventions
Eligibility Criteria
You may qualify if:
- All patient with an indication of breast non conserving surgery
You may not qualify if:
- Standard contra-indication for ambulatory care.
- Also bilateral surgery and immediate breast reconstruction.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Centre Hospitalier Universitaire, Amienslead
- Centre Hospitalier de Beauvaiscollaborator
- Centre Hospitalier de Saint-Quentincollaborator
Study Sites (1)
CHU Amiens
Amiens, 80480, France
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Elodie Demblocque, MD
Centre Hospitalier de Beauvais
- PRINCIPAL INVESTIGATOR
Albine Mancaux, MD
Centre Hospitalier de Beauvais
- PRINCIPAL INVESTIGATOR
Pierrick Theret, MD
CH SAINT-QUENTIN
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 12, 2020
First Posted
February 17, 2020
Study Start
January 1, 2021
Primary Completion
September 12, 2023
Study Completion
September 12, 2023
Last Updated
September 13, 2023
Record last verified: 2023-09
Data Sharing
- IPD Sharing
- Will not share